ZAMBART Project is apublic health researchnon-governmental organization conducting scientific research into the dual epidemics oftuberculosis andHIV. The organization is based inLusaka, Zambia at theUniversity of Zambia's School of Medicine Ridgeway Campus. ZAMBART has over 200 employees and works in 16 study sites throughout the country.
The Zambia AIDS Related Tuberculosis (ZAMBART) Project is a Zambian NGO formed in 2004 from a collaboration between the University of Zambia’s School of Medicine and theLondon School of Hygiene and Tropical Medicine that spans more than 20 years. From the initial studies of the impact of HIV on the clinical presentation and outcome of tuberculosis, the scope and partnership of the research have expanded widely. Based inLusaka, ZAMBART now collaborates closely with government, non-governmental and academic institutions within Zambia, Africa and the rest of the world. ZAMBART staff form an interdisciplinary team with a range of expertise includingepidemiology, clinical science,social science,laboratory, operations research, health systems and services research, health policy analysis,health economics,development communication and counselling.
ZAMBART focuses on the overlap between HIV and TB to improve the quality of life of people affected by the dual epidemic.[1] Conducting research within a limited resource setting, ZAMBART is committed to bridging research and action through operational research and through forging effective collaboration with local stakeholders; providing evidence-based and high-quality research; addressing relevant scientific and priority questions; andcapacity building for Zambianresearch - both scientific and managerial.
Internationally, ZAMBART is recognised as one of the foremost TB/HIV research groups in the world. Representatives sit on theWorld Health Organization (WHO) TB/HIV working group and have assisted in the writing of WHO technical guidelines andpolicy documents. In addition, ZAMBART is actively involved in regional and international research consortia through TARGETS, Evidence for Action and the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE).
ZAMBART has no core funding but has been successful in attracting grants from a wide range of sources. Much of the current portfolio of activity is funded through the Department For International Development (DFID) Knowledge Programmes on Tuberculosis (TARGETS) and HIV (Evidence for Action) and the CREATE Consortium, funded by theBill and Melinda Gates Foundation.